SPY424.31+0.70 0.17%
DIA345.12+0.14 0.04%
IXIC14,069.42+49.09 0.35%

Cassava Sciences Receives $2.7 Million Research Grant From the National Institutes of Health

05/12/2021 05:20

09:15 AM EDT, 05/12/2021 (MT Newswires) -- Cassava Sciences (SAVA) on Wednesday said it has received a new $2.7 million research grant award from the National Institutes of Health which it will use to fund clinical readiness activities in support of its upcoming phase 3 program with the Alzheimer's disease drug candidate simufilam.

The research grant was awarded following peer review of clinical and scientific data for simufilam, the company said.

Price: 39.05, Change: -0.18, Percent Change: -0.46